针对巨细胞表型治疗心力衰竭:一种新方法
Min Shi1,2, Hui Yuan2,3, Ya Li4
1School of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
Drug design, development and therapy
|November 11, 2024
概括
巨细胞是心力衰竭 (HF) 中的关键免疫细胞. 向巨细胞的功能,如两极化和亡,为HF治疗提供了有前途的新疗法策略.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管疾病 心血管疾病
- 细胞生物学 细胞生物学
背景情况:
- 心力衰竭 (HF) 是一个严重的全球健康负担,治疗选择有限.
- 巨细胞,先天性免疫细胞,越来越多地被认为在HF病变发生过程中的关键作用.
- 了解巨细胞功能对于开发新型HF疗法至关重要.
研究的目的:
- 在心力衰竭的背景下,审查巨细胞的多方面的生物功能.
- 探索巨细胞两极分化,热,自和亡是如何促进HF发育的.
- 突出调节HF中巨细胞表型的治疗潜力.
主要方法:
- 关于巨细胞生物学和心力衰竭的当前科学文献的综述.
- 分析巨细胞的功能,包括细胞分裂,免疫反应和组织修复.
- 讨论细胞过程,如极化,热,自和HF病原体的亡.
主要成果:
- 巨细胞显著影响心脏平衡和高血压中应激反应.
- 关键的巨细胞过程,如极化,热,自和亡,都深深地涉及到HF.
- 调节巨细胞表型可以影响免疫炎症,纤维化,新陈代谢和血管生成.
结论:
- 巨细胞是心力衰竭的有希望的治疗点.
- 向巨细胞功能提供了改善HF结果的潜在策略.
- 对巨细胞调节的进一步研究可能会导致新的HF治疗方法.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K